← Back to headlines
Moderna Begins First Human Trial of Bundibugyo Ebola Vaccine
Moderna has initiated the first human trial for its vaccine targeting the Bundibugyo strain of the Ebola virus.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Experts Urge Early Preparation for Hotter Summers, Beyond Air Conditioning
44m ago
Excessive Protein Intake Poses Risks to Kidneys and Increases Cancer Risk
56m ago
Human Lifespan Could Reach 200 Years, Limited by Cell Damage
57m ago
Medicare Patient Faces Double Deductible Payment After Short Hospital Stay
58m ago